e-learning
resources
Monograph
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Post-transplant lymphoproliferative disease and other malignancies
E.A.M. Verschuuren
Source:
Eur Respir Mon; 2009: 45: 226–237
Journal Issue:
Lung Transplantation
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E.A.M. Verschuuren. Post-transplant lymphoproliferative disease and other malignancies. Eur Respir Mon; 2009: 45: 226–237
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Severe haemoptysis
Related content which might interest you:
Lymphoproliferative disease and other malignancies
Source: ERS Course 2016
Year: 2016
The role of EBV DNAemia in the assessment of post-transplant lymphoproliferative disorders (PTLD)
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Could LDH monitoring after lung transplantation be used as screening tool for post-transplant lymphoproliferative disorder (PTLD)?
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017
Post-transplant bronchiolitis
Source: Annual Congress 2004 - PG14 - Bronchiolitis in adults
Year: 2004
Pulmonary manifestations of haematological diseases: from lymphoma to sickle cell crisis
Source: International Congress 2018 – Respiratory medicine meets hematology
Year: 2018
Clonality analysis in lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 306s
Year: 2006
Sarcoidosis and autoimmune thyroid disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Pulmonary veno-occlusive disease in myeloproliferative disorder
Source: Eur Respir J 2009; 33: 213-216
Year: 2009
Manifestations of malignancies during the course of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Differential diagnosis of drug-induced toxicity and infectious disorder in haematological malignancies
Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity
Year: 2009
Pulmonary complications in patients with hematologic diseases
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir Rev 2015; 24: 400-410
Year: 2015
Medical complications of lung transplantation
Source: Eur Respir J 2004; 23: 334-342
Year: 2004
A rare CNS manifestation of pulmonary Tcell lymphoma
Source: Eur Respir J 2007; 30: Suppl. 51, 99s
Year: 2007
Sixteen years‘ experience of lymphoproliferative disease following lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007
Prevalance of pulmonary hypertension in chronic myeloproliferative diseases
Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Year: 2011
Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept